By Blake Brittain (Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that ...
The report said GSK’s former head of vaccine development, Philip Dormitzer, who joined the company after working at ...
In 2020, many companies tried to develop effective coronavirus vaccines, but two ended up succeeding and dominating the field ...
President Trump has claimed in the past Pfizer sat on positive vaccine data, but no evidence has supported the accusation.
(Reuters) -Federal prosecutors in Manhattan are probing a claim by GSK that Pfizer delayed announcing its COVID shot's ...
Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...
The Kansas Supreme Court is weighing whether to block a sweeping state law that lets workers easily bypass COVID-19 vaccine ...
The delayed decision comes amid a major organizational shakeup that included the departure of top vaccine official Peter ...
Years after the biopharmaceutical industry stepped up to create COVID-19 vaccines as the virus spiraled into a global ...
Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The ...
Pfizer stock slipped about 0.7% to $25.19 after The Wall Street Journal reported on an inquiry looking into the suggestion ...
Just two days after Democrat Joe Biden was declared the winner of the 2020 presidential election, drugmaker Pfizer announced ...